Homology Medicines Inc.

1.10-0.0050-0.45%Vol 18.13K1Y Perf -50.45%
Jun 8th, 2023 11:26 DELAYED
BID1.09 ASK1.10
Open1.10 Previous Close1.10
Pre-Market- After-Market-
 - -%  - -
Target Price
8.75 
Analyst Rating
Moderate Buy 1.67
Potential %
695.53 
Finscreener Ranking
★★★★★     63.70
Insiders Trans % 3/6/12 mo.
-/-/-100 
Value Ranking
★★★★     57.06
Insiders Value % 3/6/12 mo.
-/-/-100 
Growth Ranking
★★★★★     67.84
Insiders Shares Cnt. % 3/6/12 mo.
-/-/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
9.63 
Earnings Rating
Strong Buy
Market Cap63.29M 
Earnings Date
15th May 2023
Alpha-0.03 Standard Deviation0.18
Beta-0.07 

Today's Price Range

1.071.10

52W Range

0.86003.30

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
10.22%
1 Month
8.91%
3 Months
-25.68%
6 Months
-23.08%
1 Year
-50.45%
3 Years
-93.37%
5 Years
-94.68%
10 Years
-

TickerPriceChg.Chg.%
FIXX1.10-0.0050-0.45
AAPL179.201.38000.78
GOOG123.380.44000.36
MSFT326.052.67000.83
XOM108.10-0.4300-0.40
WFC41.68-0.3900-0.93
JNJ158.850.32500.21
FB---
GE107.101.02000.96
JPM139.84-0.8500-0.60
ProfitabilityValueIndustryS&P 500US Markets
-
-4 127.60
-4 031.90
-
-28.78
RevenueValueIndustryS&P 500US Markets
2.41M
0.04
91.32
-
Earnings HistoryEstimateReportedSurprise %
Q01 2023-0.55-0.509.09
Q04 2022-0.51-0.60-17.65
Q03 2022-0.47-0.59-25.53
Q02 2022-0.57-0.5110.53
Q01 2022-0.25-0.2020.00
Q04 2021-0.58-0.59-1.72
Q03 2021-0.60-0.5410.00
Q02 2021-0.58-0.546.90
Earnings Per EndEstimateRevision %Trend
6/2023 QR-0.466.12Positive
9/2023 QR-0.438.51Positive
12/2023 FY-1.825.21Positive
12/2024 FY-1.1330.67Positive
Next Report Date-
Estimated EPS Next Report-0.55
Estimates Count4
EPS Growth Next 5 Years %37.10
Volume Overview
Volume18.13K
Shares Outstanding57.79K
Shares Float41.71M
Trades Count49
Dollar Volume19.87K
Avg. Volume96.91K
Avg. Weekly Volume63.60K
Avg. Monthly Volume83.73K
Avg. Quarterly Volume143.40K

Homology Medicines Inc. (NASDAQ: FIXX) stock closed at 1.1 per share at the end of the most recent trading day (a 5.77% change compared to the prior day closing price) with a volume of 91.02K shares and market capitalization of 63.28M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 206 people. Homology Medicines Inc. CEO is Arthur O. Tzianabos.

The one-year performance of Homology Medicines Inc. stock is -50.45%, while year-to-date (YTD) performance is -12.7%. FIXX stock has a five-year performance of -94.68%. Its 52-week range is between 0.86 and 3.3, which gives FIXX stock a 52-week price range ratio of 9.63%

Homology Medicines Inc. currently has a PE ratio of -15.80, a price-to-book (PB) ratio of 0.43, a price-to-sale (PS) ratio of 39.42, a price to cashflow ratio of 57.40, a PEG ratio of 2.32, a ROA of -1.74%, a ROC of -2.39% and a ROE of -2.11%. The company’s profit margin is -28.78%, its EBITDA margin is -4 031.90%, and its revenue ttm is $2.41 Million , which makes it $0.04 revenue per share.

Of the last four earnings reports from Homology Medicines Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.55 for the next earnings report. Homology Medicines Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Homology Medicines Inc. is Moderate Buy (1.67), with a target price of $8.75, which is +695.53% compared to the current price. The earnings rating for Homology Medicines Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Homology Medicines Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Homology Medicines Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.41, ATR14 : 0.07, CCI20 : 125.79, Chaikin Money Flow : 0.11, MACD : 0.00, Money Flow Index : 51.89, ROC : 3.77, RSI : 61.60, STOCH (14,3) : 93.75, STOCH RSI : 1.00, UO : 51.95, Williams %R : -6.25), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Homology Medicines Inc. in the last 12-months were: Albert Seymour (Option Excercise at a value of $0), Albert Seymour (Sold 7 240 shares of value $10 067 ), Alloway Paul (Sold 10 965 shares of value $15 899 ), Arthur O. Tzianabos (Option Excercise at a value of $0), Arthur O. Tzianabos (Sold 21 232 shares of value $29 523 ), Michael Blum (Option Excercise at a value of $0), Michael Blum (Sold 2 454 shares of value $3 412 ), Paul Alloway (Option Excercise at a value of $0), Paul Alloway (Sold 14 055 shares of value $20 159 ), W. Bradford Smith (Option Excercise at a value of $0), W. Bradford Smith (Sold 7 458 shares of value $10 376 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
6 (66.67 %)
6 (66.67 %)
5 (71.43 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (33.33 %)
3 (33.33 %)
2 (28.57 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.67
Moderate Buy
1.67
Strong Buy
1.57

Homology Medicines Inc.

Homology Medicines Inc is an US based is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.

CEO: Arthur O. Tzianabos

Telephone: +1 781 301-7277

Address: One Patriots Park, Bedford 01730, MA, US

Number of employees: 206

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

61%39%

Bearish Bullish

62%38%

Bearish Bullish

59%41%

 

TipRanks News for FIXX

Tue, 16 May 2023 01:45 GMT Homology Medicines (FIXX) Gets a Hold from RBC Capital

- TipRanks. All rights reserved.

Wed, 22 Mar 2023 01:32 GMT Analysts Are Bullish on Top Healthcare Stocks: Homology Medicines (FIXX), Mereo Biopharma Group Plc (MREO)

- TipRanks. All rights reserved.

Tue, 14 Mar 2023 02:05 GMT Homology Medicines (FIXX) Gets a Hold from Stifel Nicolaus

- TipRanks. All rights reserved.

Mon, 13 Mar 2023 05:55 GMT Homology Medicines (FIXX) Gets a Buy from Robert W. Baird

- TipRanks. All rights reserved.

News

Stocktwits